Video Intervention to Improve Understanding of Diabetic Retinopathy at Zuckerberg San Francisco General Hospital and Trauma Center
Part of paid clinical trials in San Francisco, California.
- Sponsor
- University of California, San Francisco
- Study ID
- NCT07519707
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Diabetic Retinopathy (DR)
- Macular Edema (ME)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Animated Videos — BEHAVIORALAnimated videos (in English and Spanish) that describe diabetic retinopathy.
Study Details
The study will evaluate whether videos can improve understanding of diabetic eye disease, and follow-up rates in the eye clinic.
Key Dates
- First listed
- Apr 9, 2026
- Start date
- Sep 30, 2026
- Status verified
- Jul 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 150 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Experimental GroupVideos
- No Intervention: ControlControl
Primary Outcome Measure
Change in Knowledge Concordance Assessed through Validated Questionarres [ Time Frame: 12 months ]
Central Contacts
- Sriranjani Padmanabhan, MD415-353-2020
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Zuckerberg San Francisco General Hospital and Trauma Center | San Francisco | California | 94110 |
Find similar trials in San Francisco, CA
Related Studies
- Assessment of AI Program 'DRISTi' as a Screening ToolRecruiting · Artelus AI · Oxford, North Carolina
- Using Implementation Science to Adapt a Targeted Transportation Intervention for Patients With Diabetic Retinopathy (PRONTO-EYE)Recruiting · University of Illinois at Chicago · Chicago, Illinois
- Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal InjectionsPHASE4 · Enrolling By Invitation · Harrow Inc · Tyler, Texas